31 Einträge gefunden

1. Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.

   1. Kern, W
   2. Haferlach, C
   3. Bacher, Ulrike
   4. Haferlach, T
   5. Schnittger, S

   2009 - Forschungsinformationssystem des UKE
2. Second allogeneic stem cell transplantation in myeloid malignancies.

   1. Hartwig, Maite
   2. Ocheni, Sunday
   3. Asenova, Svetlana
   4. Wiedemann, Bettina
   5. Zabelina, Tatjana
   6. Ayuketang Ayuk, Francis
   7. Kabisch, Hartmut

   2009 - Forschungsinformationssystem des UKE
3. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

   1. Bacher, Ulrike
   2. Badbaran, Anita
   3. Fehse, Boris
   4. Zabelina, Tatjana
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
4. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

   1. Ocheni, Sunday
   2. Zabelina, Tatjana
   3. Bacher, Ulrike
   4. Ayuketang Ayuk, Francis
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
5. Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Beelen, Dietrich
   5. Bojko, Peter
   6. Bürkle, Dieter
   7. Dengler, Robert

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
6. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Kern, Wolfgang
   4. Weiss, Tamara
   5. Haferlach, Torsten
   6. Haferlach, Claudia

   2009 - Forschungsinformationssystem des UKE
8. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

   1. Schafhausen, Philippe
   2. Dierlamm, Judith
   3. Bokemeyer, Carsten
   4. Brümmendorf, Tim
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Schnittger, Susanne

   2009 - Forschungsinformationssystem des UKE
9. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.

   1. Bacher, Ulrike
   2. Kohlmann, Alexander
   3. Haferlach, Torsten

   2009 - Forschungsinformationssystem des UKE
10. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    1. Kröger, Nicolaus
    2. Zabelina, Tatjana
    3. Binder, Thomas
    4. Ayuketang Ayuk, Francis
    5. Bacher, Ulrike
    6. Amtsfeld, Gitta
    7. Lellek, Heinrich

    2009 - Forschungsinformationssystem des UKE
11. Gene expression profiling in acute myeloid leukaemia (AML).

    1. Bacher, Ulrike
    2. Kohlmann, Alexander
    3. Haferlach, Claudia
    4. Haferlach, Torsten

    2009 - Forschungsinformationssystem des UKE
12. Severe aplastic anaemia following leflunomide therapy.

    1. Wüsthof, Mirjam
    2. Smirnova, Anna
    3. Bacher, Ulrike
    4. Kröger, Nicolaus
    5. Zander, Axel R.
    6. Schuch, Gunter
    7. Bokemeyer, Carsten

    2009 - Forschungsinformationssystem des UKE
13. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia-a report from the German Registry covering the period from 1998 to 2004.

    1. Bacher, Ulrike
    2. Klyuchnikov, Evgeny
    3. Zabelina, Tatjana
    4. Ottinger, Hellmut
    5. Beelen, Dietrich
    6. Schrezenmeier, Hubert
    7. Ehninger, Gerhard

    2009 - Forschungsinformationssystem des UKE
14. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.

    1. Haferlach, T
    2. Kohlmann, A
    3. Klein, H-U
    4. Ruckert, C
    5. Dugas, M
    6. Williams, P M
    7. Kern, W

    2009 - Forschungsinformationssystem des UKE
15. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Kern, Wolfgang
    4. Weiss, Tamara
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2009 - Forschungsinformationssystem des UKE
16. Interactive diagnostics in the indication to allogeneic SCT in AML.

    1. Bacher, Ulrike
    2. Haferlach, C
    3. Schnittger, S
    4. Kern, W
    5. Kröger, Nicolaus
    6. Zander, Axel R.
    7. Haferlach, T

    2009 - Forschungsinformationssystem des UKE
17. Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment.

    1. Haferlach, C
    2. Bacher, Ulrike
    3. Schnittger, S
    4. Weiss, T
    5. Kern, W
    6. Haferlach, T

    2009 - Forschungsinformationssystem des UKE
18. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    1. Klyuchnikov, Evgeny
    2. Schafhausen, Philippe
    3. Kröger, Nicolaus
    4. Brümmendorf, Tim
    5. Osanmaz, Okay
    6. Asenova, Svetlana
    7. Zabelina, Tatjana

    2009 - Forschungsinformationssystem des UKE
19. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

    1. Bacher, Ulrike
    2. Asenova, Svetlana
    3. Badbaran, Anita
    4. Zander, Axel R.
    5. Alchalby, Haefaa
    6. Fehse, Boris
    7. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE
20. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

    1. Klyuchnikov, Evgeny
    2. Kröger, Nicolaus
    3. Brümmendorf, Tim
    4. Wiedemann, Bettina
    5. Zander, Axel R.
    6. Bacher, Ulrike

    2009 - Forschungsinformationssystem des UKE